Copertina

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Eman Mshari, Caroline S. Copeland, Georgia C. Richards
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	British Journal of Clinical Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Drug poisonings following bariatric surgery: Case series report
di: Eman Mshari, et al.
Pubblicazione: (2025)

Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales
di: Sheila Macdonald Bird
Pubblicazione: (2024)

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales
di: Catrin O. Plumpton, et al.
Pubblicazione: (2026)

Adherence to evidence‐based practice in the treatment of digoxin poisoning in New South Wales, Australia
di: Betty S. Chan, et al.
Pubblicazione: (2025)

Utilization and expenditure on medicines for the management of osteoporosis in Ireland: A repeated cross‐sectional study
di: Amelia Smith, et al.
Pubblicazione: (2025)

Trust first, concerns second: An international vignette study of older adults' preferences towards deprescribing statins
di: Sarah E. Vordenberg, et al.
Pubblicazione: (2026)

Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology
di: Louise Durand, et al.
Pubblicazione: (2024)

Discrepancies between forest plots and reported results in mineralocorticoid receptor antagonist meta‐analysis of glycaemic outcomes
di: Lekha Saha
Pubblicazione: (2026)

Letter to the editor concerning the article: ‘The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview’
di: Tamás Ágh, et al.
Pubblicazione: (2025)

A case report highlighting drug–drug interactions between 3 life‐saving treatments: Feminizing hormones, antiretrovirals and antituberculosis drugs
di: Tara Suchak, et al.
Pubblicazione: (2024)

Model based comparison of cabotegravir pharmacokinetics following thigh and gluteal injections
Pubblicazione: (2024)

Recurrent fexuprazan‐induced liver injury following unintentional re‐exposure
di: Sook Jin Seong, et al.
Pubblicazione: (2025)

Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioning
di: Beth Apsel Winger, et al.
Pubblicazione: (2025)

Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk‐proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024
di: Andrea Manfrin, et al.
Pubblicazione: (2025)

Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug–drug interaction effects: Quantitative and qualitative results from the ACCURATE‐DDI study
di: E. Ready, et al.
Pubblicazione: (2025)

Favipiravir pharmacokinetics in saliva, tears and nasal secretions of hospitalized COVID‐19 patients following intravenous favipiravir administration
Pubblicazione: (2024)

Rerouting cardiovascular management following gastric bypass surgery: Dose optimization of carvedilol using population‐based analysis
di: Priscila Akemi Yamamoto, et al.
Pubblicazione: (2024)

Selected Abstracts from Pharmacology 2024
Pubblicazione: (2024)

Left ventricular hypertrophy reporting, analysis and trial design
di: Daniel Caldeira
Pubblicazione: (2026)

Importance of the UK Prescribing Safety Assessment as a component of undergraduate medical assessment
di: David Hepburn, et al.
Pubblicazione: (2024)

From cradle to cane—(Dis)similarities between paediatric and geriatric clinical pharmacology: A commentary arising from the 2024 International Union of Basic and Clinical Pharmacology (IUPHAR) World Smart Medication Day
di: Karel Allegaert, et al.
Pubblicazione: (2025)

Toxicokinetic modelling of the synthetic cannabinoid 5F‐MDMB‐P7AICA and its main metabolite in pigs following pulmonary administration
di: Adrian A. Doerr, et al.
Pubblicazione: (2024)

Apixaban anti‐Xa levels in clinical practice: A case report
di: Sarah Clark, et al.
Pubblicazione: (2024)

Safety, pharmacokinetics and pharmacodynamics of NXC736, a novel sphingosine‐1‐phosphate receptor modulator
di: Woo Kyung Chung, et al.
Pubblicazione: (2026)

Academic development of advanced therapies—How to foster their future in the clinic
di: Ana Hidalgo‐Simon, et al.
Pubblicazione: (2025)

Safety, pharmacokinetics and antiviral activity of ainuovirine as 10‐day monotherapy in treatment‐naïve adults with HIV‐1
Pubblicazione: (2024)

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase
di: Comfort Kunak Ogar, et al.
Pubblicazione: (2026)

Bridging the gap between clinical pharmacology and rational drug prescribing 2.0: An up‐date after 30 years
di: Erik M. Donker, et al.
Pubblicazione: (2024)

Safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HRS‐1893, a cardiac myosin inhibitor, in healthy subjects
di: Kexu Yang, et al.
Pubblicazione: (2026)

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment
di: Shibeilei Lin, et al.
Pubblicazione: (2025)

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review
di: Audrey Fresse, et al.
Pubblicazione: (2026)

Case report: Dolutegravir dosing post‐Roux‐en‐Y gastric bypass surgery
Pubblicazione: (2024)

Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review
di: Andrej Belančić, et al.
Pubblicazione: (2024)

Cefoperazone/sulbactam‐induced haemolytic anaemia and thrombocytosis: A case report and literature review
di: Quanji Ma, et al.
Pubblicazione: (2026)

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults
di: Sven C. van Dijkman, et al.
Pubblicazione: (2026)

Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study
di: L. Dickinson, et al.
Pubblicazione: (2025)

Core medication use in general practice prescriptions: A pilot study evaluating the Drug Utilization 90% Index in Irish general practice
di: Caroline McCarthy, et al.
Pubblicazione: (2024)

Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach
di: Alexandre Acramel, et al.
Pubblicazione: (2024)

Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects
di: Carina Lundby, et al.
Pubblicazione: (2024)

Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour
di: Non Davies, et al.
Pubblicazione: (2025)